Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recoflavone Phase 2 in Dry Eye Disease
NCT04679883Phase 2Unknown
- Sponsor
- GL Pharm Tech Corp
- Start
- Apr 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of recoflavone in dry eye disease (DED), sponsored by GL Pharm Tech Corp. Status: unknown.
02
Drugs
recoflavone
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04679883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04679883.